Evidence map›Paper›PMID 22019643›Full record

ArticleJournal of immunological methods2012

The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease.

Sergei I Ochkur, John Dongil Kim, Cheryl A Protheroe, Dana Colbert, Redwan Moqbel, Paige Lacy, James J Lee, Nancy A Lee

Abstract read
In one paragraph

Article in Journal of immunological methods, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Activation of donor-derived eosinophils during static storage contributes to primary graft dysfunction after lung transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  4. Article
  5. Article
  6. Assessment of Lung Eosinophils In Situ Using Immunohistological Staining.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.American journal of respiratory and critical care medicine · 2017
    Article
  13. Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation.American journal of respiratory cell and molecular biology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sergei I OchkurDivision of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, AZ 85259, United States.
John Dongil Kim
Cheryl A Protheroe
Dana Colbert
Redwan Moqbel
Paige Lacy
James J Lee
Nancy A Lee
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of Alberta · CAUniversity of Manitoba · CA

Funding

EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASER01HL065228 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI JACOBSEN, ELIZABETH A · 2000 to 2017
$6.7M
MOUSE MODELS OF EOSINOPHIL ASSOCIATED LUNG DYSFUNCTIONR01HL058723 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI LEE, NANCY A. · 1998 to 2013
$4.2M
Mechanisms of Eosinophil Effector Functions in the LungK26RR019709 · NCRR · MAYO CLINIC ARIZONA · PI LEE, JAMES JOSEPH · 2005 to 2009
$578k
Mouse Models of Eosinophil-Associated Lung DysfunctionR56HL058723 · NHLBI · MAYO CLINIC ARIZONA · PI LEE, NANCY A. · 2008 to 2008
$400k
CIHR MOP89748NCRR NIH HHS K26 RR019709NCRR NIH HHS RR0109709NHLBI NIH HHS HL058723NHLBI NIH HHS HL065228NHLBI NIH HHS R01 HL058723NHLBI NIH HHS R01 HL065228NHLBI NIH HHS R56 HL058723
6 · The paper itself

Abstract

Mouse models of eosinophilic disorders are often part of preclinical studies investigating the underlying biological mechanisms of disease pathology. The presence of extracellular eosinophil granule proteins in affected tissues is a well established and specific marker of eosinophil activation in both patients and mouse models of human disease. Unfortunately, assessments of granule proteins in the mouse have been limited by the availability of specific antibodies and a reliance on assays of released enzymatic activities that are often neither sensitive nor eosinophil specific. The ability to detect immunologically and quantify the presence of a mouse eosinophil granule protein in biological fluids and/or tissue extracts was achieved by the generation of monoclonal antibodies specific for eosinophil peroxidase (EPX). This strategy identified unique pairs of antibodies with high avidity to the target protein and led to the development of a unique sandwich ELISA for the detection of EPX. Full factorial design was used to develop this ELISA, generating an assay that is eosinophil-specific and nearly 10 times more sensitive than traditional OPD-based detection methods of peroxidase activity. The added sensitivity afforded by this novel assay was used to detect and quantify eosinophil degranulation in several settings, including bronchoalveolar fluid from OVA sensitized/challenged mice (an animal model of asthma), serum samples derived from peripheral blood recovered from the tail vasculature, and from purified mouse eosinophils stimulated ex vivo with platelet activating factor (PAF) and PAF + ionomycin. This ability to assess mouse eosinophil degranulation represents a specific, sensitive, and reproducible assay that fulfills a critical need in studies of eosinophil-associated pathologies in mice.

Indexed as

AnimalsAntibodies, MonoclonalBronchoalveolar Lavage FluidCell DegranulationEnzyme-Linked Immunosorbent AssayEosinophil Granule ProteinsEosinophil PeroxidaseEosinophilsHumansLeukocytesMiceMice, Inbred C57BLMice, KnockoutSensitivity and SpecificityAntibodies, MonoclonalEosinophil Granule ProteinsEosinophil Peroxidase

Identifiers

PMID22019643
PMCPMC3375321
OpenAlexW1965662320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.